Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Inseego put volume heavy and directionally bearish » 10:35
07/10/20
07/10
10:35
07/10/20
10:35
INSG

Inseego

$11.16 /

-0.25 (-2.19%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INSG Inseego
$11.16 /

-0.25 (-2.19%)

INSG Inseego
$11.16 /

-0.25 (-2.19%)

06/25/20 Stifel
Inseego initiated with a Buy at Stifel
05/19/20 Cowen
Inseego price target raised to $13.50 from $12 at Cowen
04/30/20 Vertical Group
Inseego initiated with a Sell at Vertical Group
04/14/20 Canaccord
Inseego price target raised to $14 from $10 at Canaccord
INSG Inseego
$11.16 /

-0.25 (-2.19%)

INSG Inseego
$11.16 /

-0.25 (-2.19%)

INSG Inseego
$11.16 /

-0.25 (-2.19%)

Recommendations
SAP price target raised to $175 from $145 at Argus » 07:11
07/10/20
07/10
07:11
07/10/20
07:11
SAP

SAP

$152.74 /

+5.99 (+4.08%)

Argus analyst Joseph…

Argus analyst Joseph Bonner raised the firm's price target on SAP to $175 from $145 and keeps a Buy rating on the shares after its better than expected preliminary Q2 results and "strong" operating margins. The analyst cites the management commentary around gradual improvement during the quarter, with a "particular strong" recovery in Software License revenue in the Asia Pacific region. Bonner adds that his new price target still implies a forward earnings multiple of 28-times, which is below the peer average multiple of 42-times.

ShowHide Related Items >><<
SAP SAP
$152.74 /

+5.99 (+4.08%)

SAP SAP
$152.74 /

+5.99 (+4.08%)

07/09/20 RBC Capital
SAP price target raised to $150 from $142 at RBC Capital
07/09/20 JMP Securities
SAP price target raised to $165 from $150 at JMP Securities
07/08/20 UBS
SAP price target raised to EUR 142 from EUR 118 at UBS
06/16/20 Oppenheimer
SAP price target raised to $137 from $115 at Oppenheimer
SAP SAP
$152.74 /

+5.99 (+4.08%)

SAP SAP
$152.74 /

+5.99 (+4.08%)

SAP SAP
$152.74 /

+5.99 (+4.08%)

Yesterday
Options
Glu Mobile call volume above normal and directionally bullish » 10:25
07/09/20
07/09
10:25
07/09/20
10:25
GLUU

Glu Mobile

$10.70 /

+0.95 (+9.74%)

Bullish option flow…

Bullish option flow detected in Glu Mobile with 46,215 calls trading, 25x expected, and implied vol increasing over 4 points to 83.27%. Jul-20 10 calls and Jul-20 11 calls are the most active options, with total volume in those strikes near 40,800 contracts. The Put/Call Ratio is 0.01. Earnings are expected on July 30th.

ShowHide Related Items >><<
GLUU Glu Mobile
$10.70 /

+0.95 (+9.74%)

GLUU Glu Mobile
$10.70 /

+0.95 (+9.74%)

06/10/20
Fly Intel: Top five analyst initiations
06/10/20 UBS
Glu Mobile initiated with a Buy at UBS
05/29/20 Benchmark
Benchmark reiterates Buy rating on Glu Mobile after guidance hike
05/29/20 Piper Sandler
Glu Mobile outlook still conservative despite uptick, says Piper Sandler
GLUU Glu Mobile
$10.70 /

+0.95 (+9.74%)

  • 04
    Jun
GLUU Glu Mobile
$10.70 /

+0.95 (+9.74%)

GLUU Glu Mobile
$10.70 /

+0.95 (+9.74%)

Upgrade
Citi upgrades Zscaler to Buy on durability of flexible workforce trend » 08:04
07/09/20
07/09
08:04
07/09/20
08:04
ZS

Zscaler

$120.98 /

+7.14 (+6.27%)

As previously reported,…

As previously reported, Citi analyst Walter Pritchard upgraded Zscaler to Buy from Neutral with a price target of $152, up from $86. Longer-term needs for a more flexible workforce and adoption of cloud applications have been pulled forward by the pandemic and he thinks this trend is sustainable, while adding that he views current competition as "benign." Pritchard, who sees Zscaler being set up for an acceleration in growth in FY21, calls it "a rare company where outlook can be more confident than a quarter and six months ago."

ShowHide Related Items >><<
ZS Zscaler
$120.98 /

+7.14 (+6.27%)

ZS Zscaler
$120.98 /

+7.14 (+6.27%)

07/09/20 Citi
Zscaler upgraded to Buy from Neutral at Citi
07/07/20 Rosenblatt
Zscaler price target raised to $135 from $115 at Rosenblatt
07/06/20 RBC Capital
Zscaler initiated with an Outperform at RBC Capital
06/22/20 Needham
Zscaler price target raised to $130 from $110 at Needham
ZS Zscaler
$120.98 /

+7.14 (+6.27%)

ZS Zscaler
$120.98 /

+7.14 (+6.27%)

ZS Zscaler
$120.98 /

+7.14 (+6.27%)

ZS Zscaler
$120.98 /

+7.14 (+6.27%)

Upgrade
Zscaler upgraded to Buy from Neutral at Citi » 07:29
07/09/20
07/09
07:29
07/09/20
07:29
ZS

Zscaler

$120.98 /

+7.14 (+6.27%)

Citi analyst Walter…

Citi analyst Walter Pritchard upgraded Zscaler to Buy from Neutral with a $152 price target.

ShowHide Related Items >><<
ZS Zscaler
$120.98 /

+7.14 (+6.27%)

ZS Zscaler
$120.98 /

+7.14 (+6.27%)

07/07/20 Rosenblatt
Zscaler price target raised to $135 from $115 at Rosenblatt
07/06/20 RBC Capital
Zscaler initiated with an Outperform at RBC Capital
06/22/20 Needham
Zscaler price target raised to $130 from $110 at Needham
06/18/20 Morgan Stanley
Morgan Stanley ups Cloudflare to Equal Weight on security architecture changes
ZS Zscaler
$120.98 /

+7.14 (+6.27%)

ZS Zscaler
$120.98 /

+7.14 (+6.27%)

ZS Zscaler
$120.98 /

+7.14 (+6.27%)

ZS Zscaler
$120.98 /

+7.14 (+6.27%)

Recommendations
SAP price target raised to $150 from $142 at RBC Capital » 07:02
07/09/20
07/09
07:02
07/09/20
07:02
SAP

SAP

$146.75 /

+2.75 (+1.91%)

RBC Capital analyst Alex…

RBC Capital analyst Alex Zukin raised the firm's price target on SAP to $150 from $142 and keeps a Sector Perform rating on the shares after its pre-announced Q2 results. The analyst says the company's Cloud revenue was slightly lower than consensus, but license and margins were "much stronger". With strength in S/4HANA ERP and in Supply Chain, the quarter was "mostly better than feared", though SAP's transactional areas were "harder hit than anticipated", Zukin tells investors in a research note.

ShowHide Related Items >><<
SAP SAP
$146.75 /

+2.75 (+1.91%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

07/09/20 JMP Securities
SAP price target raised to $165 from $150 at JMP Securities
07/08/20 UBS
SAP price target raised to EUR 142 from EUR 118 at UBS
06/16/20 Oppenheimer
SAP price target raised to $137 from $115 at Oppenheimer
06/16/20 RBC Capital
SAP price target raised to $142 from $117 at RBC Capital
SAP SAP
$146.75 /

+2.75 (+1.91%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

Recommendations
SAP price target raised to $165 from $150 at JMP Securities » 06:23
07/09/20
07/09
06:23
07/09/20
06:23
SAP

SAP

$146.75 /

+2.75 (+1.91%)

JMP Securities analyst…

JMP Securities analyst Patrick Walravens raised the firm's price target on SAP to $165 from $150 and keeps an Outperform rating on the shares after the company pre-announced Q2 with better than expected profitability and sales. The company remains "relatively well positioned" in the current environment, the analyst tells investors in a research note, citing the next-generation S/4HANA product cycle, the "evolution" of its business to more predictable revenue streams, and the growth of its cloud backlog.

ShowHide Related Items >><<
SAP SAP
$146.75 /

+2.75 (+1.91%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

07/08/20 UBS
SAP price target raised to EUR 142 from EUR 118 at UBS
06/16/20 Oppenheimer
SAP price target raised to $137 from $115 at Oppenheimer
06/16/20 RBC Capital
SAP price target raised to $142 from $117 at RBC Capital
06/15/20 Jefferies
SAP price target raised to $149 from $145 at Jefferies
SAP SAP
$146.75 /

+2.75 (+1.91%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

Wednesday
On The Fly
Fly Intel: After-Hours Movers » 18:59
07/08/20
07/08
18:59
07/08/20
18:59
EXFO

EXFO Inc.

$3.24 /

+0.1 (+3.18%)

, SAR

Saratoga Investment

$15.61 /

+0.475 (+3.14%)

, ACER

Acer Therapeutics

$3.21 /

+0.07 (+2.23%)

, OPTN

Optinose

$4.26 /

-0.28 (-6.17%)

, ANAB

AnaptysBio

$22.71 /

+0.05 (+0.22%)

, VERI

Veritone

$12.11 /

-0.26 (-2.10%)

, PTC

PTC

$78.36 /

+1.76 (+2.30%)

, SAP

SAP

$146.75 /

+2.75 (+1.91%)

, CRNX

Crinetics

$16.46 /

-0.62 (-3.63%)

, FTCH

Farfetch

$19.59 /

+1.4 (+7.70%)

, COST

Costco

$316.38 /

+0.095 (+0.03%)

, REGN

Regeneron

$639.69 /

-0.92 (-0.14%)

, BBBY

Bed Bath & Beyond

$10.40 /

+0.15 (+1.46%)

, OTIC

Otonomy

$3.58 /

+0.01 (+0.28%)

, GLG

TD Holdings

$2.44 /

+0.06 (+2.52%)

, TPB

Turning Point Brands

$26.50 /

+1.945 (+7.92%)

, FIVE

Five Below

$103.28 /

+4.72 (+4.79%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
VERI Veritone
$12.11 /

-0.26 (-2.10%)

TPB Turning Point Brands
$26.50 /

+1.945 (+7.92%)

SAR Saratoga Investment
$15.61 /

+0.475 (+3.14%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

REGN Regeneron
$639.69 /

-0.92 (-0.14%)

PTC PTC
$78.36 /

+1.76 (+2.30%)

OTIC Otonomy
$3.58 /

+0.01 (+0.28%)

OPTN Optinose
$4.26 /

-0.28 (-6.17%)

GLG TD Holdings
$2.44 /

+0.06 (+2.52%)

FTCH Farfetch
$19.59 /

+1.4 (+7.70%)

FIVE Five Below
$103.28 /

+4.72 (+4.79%)

EXFO EXFO Inc.
$3.24 /

+0.1 (+3.18%)

CRNX Crinetics
$16.46 /

-0.62 (-3.63%)

COST Costco
$316.38 /

+0.095 (+0.03%)

BBBY Bed Bath & Beyond
$10.40 /

+0.15 (+1.46%)

ANAB AnaptysBio
$22.71 /

+0.05 (+0.22%)

ACER Acer Therapeutics
$3.21 /

+0.07 (+2.23%)

EXFO EXFO Inc.
$3.24 /

+0.1 (+3.18%)

SAR Saratoga Investment
$15.61 /

+0.475 (+3.14%)

01/13/20 Ladenburg
Saratoga Investment upgraded to Buy from Neutral at Ladenburg
01/09/20 Compass Point
Saratoga Investment upgraded to Buy from Neutral at Compass Point
12/19/19 National Securities
Saratoga Investment initiated with a Neutral at National Securities
08/29/19 Aegis
Saratoga Investment initiated with a Buy at Aegis
ACER Acer Therapeutics
$3.21 /

+0.07 (+2.23%)

OPTN Optinose
$4.26 /

-0.28 (-6.17%)

06/30/20 Cantor Fitzgerald
OptiNose anti-COVID-19 candidate could provide 'significant upside, says Cantor
02/07/20 Piper Sandler
Piper Sandler views Optinose risk/reward as attractive after allergist survery
12/18/19 Cowen
Optinose initiated with an Outperform at Cowen
10/01/19 Jefferies
Optinose risk/reward looks increasingly attractive, says Jefferies
ANAB AnaptysBio
$22.71 /

+0.05 (+0.22%)

01/16/20 Cantor Fitzgerald
AnaptysBio risk/reward favorable into second half data, says Cantor Fitzgerald
11/11/19 SunTrust
AnaptysBio downgraded to Hold from Buy at SunTrust
11/08/19 Cantor Fitzgerald
Cantor cuts AnaptysBio target to $28 from $140, sees value in shares
11/08/19 Jefferies
AnaptysBio downgraded to Hold from Buy at Jefferies
VERI Veritone
$12.11 /

-0.26 (-2.10%)

07/06/20 Craig-Hallum
Craig-Hallum says sell Veritone after stock surpasses 'reasonable' valuation
07/06/20 Craig-Hallum
Veritone downgraded to Sell from Hold at Craig-Hallum
06/25/20 Roth Capital
Veritone price target raised to $18 from $7 at Roth Capital
11/08/19 JMP Securities
Veritone price target lowered to $7 from $10 at JMP Securities
PTC PTC
$78.36 /

+1.76 (+2.30%)

06/11/20 Rosenblatt
PTC's highly recurring revenue model underappreciated, says Rosenblatt
06/11/20 Wedbush
PTC price target raised to $78 from $70 at Wedbush
06/10/20 Mizuho
PTC price target raised to $95 from $80 at Mizuho
06/05/20 Needham
PTC initiated with a Buy at Needham
SAP SAP
$146.75 /

+2.75 (+1.91%)

07/08/20 UBS
SAP price target raised to EUR 142 from EUR 118 at UBS
06/16/20 Oppenheimer
SAP price target raised to $137 from $115 at Oppenheimer
06/16/20 RBC Capital
SAP price target raised to $142 from $117 at RBC Capital
06/15/20 Jefferies
SAP price target raised to $149 from $145 at Jefferies
CRNX Crinetics
$16.46 /

-0.62 (-3.63%)

05/11/20 Cantor Fitzgerald
Crinetics price target raised to $38 from $28 at Cantor Fitzgerald
05/08/20 Piper Sandler
Piper Sandler continues to recommend Crinetics after paltusotine data
04/07/20 Piper Sandler
Crinetics shares 'should be up meaningfully,' says Piper Sandler
12/23/19 Roth Capital
Crinetics initiated with a Buy at Roth Capital
FTCH Farfetch
$19.59 /

+1.4 (+7.70%)

07/08/20 China Renaissance
Farfetch upgraded to Buy from Hold at China Renaissance
07/01/20 Deutsche Bank
Farfetch price target raised to $23 from $17 at Deutsche Bank
06/26/20 KeyBanc
Farfetch price target raised to $23 from $17 at KeyBanc
06/25/20 BTIG
Farfetch upgraded to Buy from Neutral at BTIG
COST Costco
$316.38 /

+0.095 (+0.03%)

05/29/20 Baird
Costco improved comps seen likely for May, says Baird
05/29/20 RBC Capital
Costco price target raised to $348 from $332 at RBC Capital
05/06/20 Baird
Costco SSS decline due to pressure from temporal factors, says Baird
04/15/20 Citi
Costco assumed with a Neutral at Citi
REGN Regeneron
$639.69 /

-0.92 (-0.14%)

07/08/20 SunTrust
Regeneron upgraded to Buy at SunTrust on Eylea resilience and pipeline
07/08/20 SunTrust
Regeneron upgraded to Buy from Hold at SunTrust
07/08/20 Canaccord
Regeneron price target raised to $700 from $660 at Canaccord
07/01/20 Oppenheimer
Regeneron price target raised to $675 from $625 at Oppenheimer
BBBY Bed Bath & Beyond
$10.40 /

+0.15 (+1.46%)

07/07/20 Raymond James
Bed Bath & Beyond price target raised to $13 from $9 at Raymond James
05/26/20 Odeon Capital
Bed Bath & Beyond upgraded to Buy from Hold at Odeon Capital
04/16/20 Loop Capital
Bed Bath & Beyond Q4 results 'less bad than feared' says Loop Capital
04/08/20 Loop Capital
Bed Bath & Beyond price target lowered to $5 from $12 at Loop Capital
OTIC Otonomy
$3.58 /

+0.01 (+0.28%)

07/07/20 Cantor Fitzgerald
Otonomy price target raised to $11 from $9 at Cantor Fitzgerald
07/07/20 H.C. Wainwright
Otonomy price target raised to $9 from $8 at H.C. Wainwright
06/15/20 Piper Sandler
Piper remains optimistic on Otonomy ahead of near-term clinical readouts
06/01/20 Oppenheimer
Otonomy assumed with an Outperform at Oppenheimer
GLG TD Holdings
$2.44 /

+0.06 (+2.52%)

TPB Turning Point Brands
$26.50 /

+1.945 (+7.92%)

07/08/20 Craig-Hallum
Turning Point Brands initiated with a Buy at Craig-Hallum
01/06/20 Buckingham
Vape plan looks better than expected for Turning Point, says Buckingham
11/26/19 Buckingham
Buckingham starts Turning Point at Buy, says 'far more than a vaping play'
11/26/19 Buckingham
Turning Point Brands initiated with a Buy at Buckingham
FIVE Five Below
$103.28 /

+4.72 (+4.79%)

06/10/20
Fly Intel: Top five analyst upgrades
06/10/20 JPMorgan
Five Below price target raised to $123 from $103 at JPMorgan
06/10/20 Jefferies
Five Below price target raised to $140 from $89 at Jefferies
06/10/20 Credit Suisse
Five Below price target raised to $116 from $93 at Credit Suisse
VERI Veritone
$12.11 /

-0.26 (-2.10%)

TPB Turning Point Brands
$26.50 /

+1.945 (+7.92%)

SAR Saratoga Investment
$15.61 /

+0.475 (+3.14%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

REGN Regeneron
$639.69 /

-0.92 (-0.14%)

PTC PTC
$78.36 /

+1.76 (+2.30%)

OTIC Otonomy
$3.58 /

+0.01 (+0.28%)

OPTN Optinose
$4.26 /

-0.28 (-6.17%)

FTCH Farfetch
$19.59 /

+1.4 (+7.70%)

FIVE Five Below
$103.28 /

+4.72 (+4.79%)

EXFO EXFO Inc.
$3.24 /

+0.1 (+3.18%)

CRNX Crinetics
$16.46 /

-0.62 (-3.63%)

COST Costco
$316.38 /

+0.095 (+0.03%)

BBBY Bed Bath & Beyond
$10.40 /

+0.15 (+1.46%)

ANAB AnaptysBio
$22.71 /

+0.05 (+0.22%)

ACER Acer Therapeutics
$3.21 /

+0.07 (+2.23%)

  • 09
    Jul
  • 09
    Jul
  • 27
    May
  • 15
    Apr
  • 21
    Nov
SAP SAP
$146.75 /

+2.75 (+1.91%)

REGN Regeneron
$639.69 /

-0.92 (-0.14%)

COST Costco
$316.38 /

+0.095 (+0.03%)

BBBY Bed Bath & Beyond
$10.40 /

+0.15 (+1.46%)

SAR Saratoga Investment
$15.61 /

+0.475 (+3.14%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

REGN Regeneron
$639.69 /

-0.92 (-0.14%)

OTIC Otonomy
$3.58 /

+0.01 (+0.28%)

FTCH Farfetch
$19.59 /

+1.4 (+7.70%)

FIVE Five Below
$103.28 /

+4.72 (+4.79%)

EXFO EXFO Inc.
$3.24 /

+0.1 (+3.18%)

COST Costco
$316.38 /

+0.095 (+0.03%)

BBBY Bed Bath & Beyond
$10.40 /

+0.15 (+1.46%)

ACER Acer Therapeutics
$3.21 /

+0.07 (+2.23%)

REGN Regeneron
$639.69 /

-0.92 (-0.14%)

FTCH Farfetch
$19.59 /

+1.4 (+7.70%)

FIVE Five Below
$103.28 /

+4.72 (+4.79%)

COST Costco
$316.38 /

+0.095 (+0.03%)

BBBY Bed Bath & Beyond
$10.40 /

+0.15 (+1.46%)

Earnings
SAP sees Q2 non-IFRS cloud revenue up 19%, affirms FY20 outlook » 16:54
07/08/20
07/08
16:54
07/08/20
16:54
SAP

SAP

$146.75 /

+2.75 (+1.91%)

Sees Q2 cloud backlog up…

Sees Q2 cloud backlog up 20%. The company affirms its FY20 non-IFRS cloud revenue of EUR8.3B-EUR8.7B, up 18%-24% from last year at constant currencies. The outlook "continues to be based on the assumption of a gradually improving demand environment in the third and fourth quarter as economies reopen further and population lockdowns ease."Reference Link

ShowHide Related Items >><<
SAP SAP
$146.75 /

+2.75 (+1.91%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

07/08/20 UBS
SAP price target raised to EUR 142 from EUR 118 at UBS
06/16/20 Oppenheimer
SAP price target raised to $137 from $115 at Oppenheimer
06/16/20 RBC Capital
SAP price target raised to $142 from $117 at RBC Capital
06/15/20 Jefferies
SAP price target raised to $149 from $145 at Jefferies
SAP SAP
$146.75 /

+2.75 (+1.91%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

Recommendations
SAP price target raised to EUR 142 from EUR 118 at UBS » 14:50
07/08/20
07/08
14:50
07/08/20
14:50
SAP

SAP

$146.60 /

+2.6 (+1.81%)

UBS analyst Michael…

UBS analyst Michael Briest raised the firm's price target on SAP to EUR 142 from EUR 118 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
SAP SAP
$146.60 /

+2.6 (+1.81%)

SAP SAP
$146.60 /

+2.6 (+1.81%)

06/16/20 Oppenheimer
SAP price target raised to $137 from $115 at Oppenheimer
06/16/20 RBC Capital
SAP price target raised to $142 from $117 at RBC Capital
06/15/20 Jefferies
SAP price target raised to $149 from $145 at Jefferies
04/22/20 RBC Capital
SAP downgraded to Sector Perform from Outperform at RBC Capital
SAP SAP
$146.60 /

+2.6 (+1.81%)

SAP SAP
$146.60 /

+2.6 (+1.81%)

SAP SAP
$146.60 /

+2.6 (+1.81%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.